Sherbrooke Park Advisers LLC Enanta Pharmaceuticals Inc Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 33,451 shares of ENTA stock, worth $238,840. This represents 0.06% of its overall portfolio holdings.
Number of Shares
33,451Holding current value
$238,840% of portfolio
0.06%Shares
2 transactions
Others Institutions Holding ENTA
# of Institutions
107Shares Held
18.3MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$15.1 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$14.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$13.2 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$10.7 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.22MShares$8.72 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $148M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...